SAW Instruments GmbH to Exhibit at PEGS 2012

Published: Apr 24, 2012

Bonn, Germany – 24 April 2012 – SAW Instruments, developer of the innovative sam® family of biosensors for real-time, label-free assays using viable cells, will showcase its sam®X acoustic biosensor at Booth 12 of this year’s Protein Engineering Summit (PEGS) in Boston, MA, USA (April 30th- May 4th). As the latest high-end addition to the SAW family of sam® biosensors, the sam®X expands the breadth and flexibility of the workflow options offered by the range, making it a powerful tool for applications including the investigation of molecular interactions, protein-binding studies, the screening of small molecules for drug discovery and more. Using the approach, researchers can rapidly generate insightful real-time binding data, without having to worry about the unnatural effects caused by protein labelling, purification or cellular fixation.

Having recently launched the Biosensor Access Program (BAP), a visit to booth 12 also provides the perfect opportunity to find out more about this exciting initiative. The program offers a six month lease of the sam®X, including four free packs of CM short dextran chips for cell work and four free days of application training worth $10,000. With the additional option to purchase the sam®X after six months, the Biosensor Access Program provides the perfect opportunity to see how the sam®X would transform the measurement of biomolecular interactions in your laboratory.

Please note, the sam®X Biosensor Access Program is a limited time offer. To apply for this promotion, please contact Ian Taylor ( before 18th May 2012 - act quickly as there are only a limited number of systems available!

For more information please visit the SAW Instruments website at

Notes on the technology

Surface Acoustic Wave technology is based on the ability of a wave of energy to travel across the surface of a material. Each surface has a typical inherent elasticity affecting the way the energy of the wave dissipates as it travels across the surface of the material being analysed. Thus, the nature of the surface in question, and therefore any changes to it, can be assessed by sensors monitoring the behaviour of the wave as it propagates across the surface. In particular, changes in mass result in alterations to the phase of the wave, whilst viscoelastic and conformational characteristics influence wave amplitude. The technology developed and employed by SAW instruments is capable of accurately interpreting this information in order to provide real time readouts measuring binding and conformational changes in the samples through which the wave passes.

About SAW Instruments GmbH

SAW Instruments GmbH, headquartered in Bonn, Germany, designs, develops and sells biosensor-based laboratory instruments for life sciences research. The proprietary technology of SAW Instruments employs a Surface Acoustic Waves approach to biological measurement, rather than using traditional optical methods such as SPR. The technology is uniquely positioned compared to other biosensor technologies based on its ability to measure antibody binding to whole cells, protein small molecule binding in high DMSO, and conformational changes in proteins caused by ligand binding. In addition, the system is also capable of providing other industry standard measurements including those involving concentration, kinetics and affinity.

SAW instruments has more than ten years experience in the field of label-free biosensor technology and a number of our customers have successfully published work employing the platform. It is our goal is to continue to build on this experience, as well as to develop a family of workflow-driven products to further meet our customers’ needs.

About SAW Instruments USA, LLC

SAW Instruments USA, LLC is a wholly owned US subsidiary of SAW Instruments GmbH

Back to news